Unlike conventional class actions, the plaintiffs in thefen-phen diet drug suit that went to trial last Wednesday inMiddlesex County haven’t suffered illness or injury. In fact,their class is specifically defined to exclude people who’vesuffered illness or injury.
“We are not here for money; we are here for monitoring,”said plaintiff’s lead counsel Esther Berezofsky, a partner withCherry Hill’s Williams & Cuker, during opening arguments. “Earlyintervention is important. If people can get treatment, peoplecan get help.”
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
